Esfam Biotech

Esfam Biotech

Melbourne Based Muti Asset Biopharmaceutical Company focused on solving significant unmet needs in global healthcare.

Stage Product In Development
Industry Biotechnology
Location Heidelberg VIC, Australia
Currency AUD
Founded August 2016
Employees 3
Incorporation Type C-corp
Website esfambiotech.com.au

Company Summary

Esfam discovered a new cellular target (a new way to treat diseases) and developed 2 small molecules (2 new drugs) that use the new target - treating advanced Cancer & Infectious diseases. The 1st is Esfam 269 Cancer-agnostic applications 2nd Esfam 289 has broad-spectrum antiviral activity. Globally recognised scientific leadership, spun out of leading University, wholly owned IP, Patents & Pre IND-FDA approvals ready for Toxicology & The Clinic.

Team

Penelope Lane Esfam Biotech Managing Director

Managing Director and Chief Executive Officer

A global business leader in the commercialisation of Bio & Med Tech. MD, CEO, Advisor & NED. Prior leadership roles with multinational Pharma & MedTech, leading Universities, Government & Healthcare including the WHO. Led & exited 2 early R & D companies to global MedTech. Advisory boards; Sheba Medical Centre, Israel; Swinburn Uni & RMIT. Founder Vert & Or Advisory, Angel investor focus on Bio & MedTech & healthcare impact & equity of access
Albert Frauman

Founder, Chief Medical Officer and Executive Director

Chair of the Department of Clinical Pharmacology and Therapeutics and Research Integrity advisor for Austin Health.

Professor of Clinical Pharmacology & Therapeutics at The University of Melbourne since 2007.

Practicing Endocrinologist at Austin Health.

Served as Medical Director of Nucleus Network.

Over 70 peer-reviewed publications in autoimmunity, viral infection and biomarkers of cancer progression, globally cited research expert.
Thomas Collins

Chief Financial Officer & Financial Controller

Globally Accredited & Experienced CFO & Controller.
Global positions; Sheridan Pacific Brands, Coleman Brands, Pure Fishing ANZ, Jarden. NED, Chairman Berowra & District Financial Services
Committed to adding value as part of commercially minded leadership teams. Expertise in the economics of business and company processes to grow sales & profit margins focused on prosperity in partnership & shared value.
Paul Scagliotti

Company Secretary; Head of Law, Risk & Governance and Chief Operating Officer.

Commercially oriented lawyer; skilled in technical & regulated health tech commercialisation industries. Commerce, Law & Masters health law qualifications, member of the Governance Institute of Aus. Experienced in law, governance & risk mitigation in early-stage health, medical & life sciences tech. Prior engagements: DLA Piper, Mills Oakley, Concepta Private Equity, ResMed, UNSW Wesfarmers Health, Uni of NSW, Monash Uni , La Trobe & RMIT.